After Success Against COVID-19 Variants, Novavax Will File Vaccine First In UK

Efficacy Lower Against South Africa Strain

29 Jan 2021

• By Andrew McConaghie

High efficacy in initial readout is good news for global vaccination, and UK will see first emergency use filing.

South African community healthcare workers — THE TRIALS IN THE UK AND SOUTH AFRICA MEANT NOVAVAX IS THE FIRST TO TEST A VACCINE AGAINST THE NEW SARS-COV2 VARIANTS FIRST IDENTIFIED IN THESE COUNTRIES.

More from Europe

More from Geography